MétaCan
Menu
← Back to cohort
Record W4285730398 · doi:10.21203/rs.3.rs-1634347/v1

Safety and Feasibility of Faecal Microbiota Transplant for Major Depressive Disorder: Study Protocol for a Pilot Randomised Controlled Trial

2022· preprint· en· W4285730398 on OpenAlexaff
Jessica Green, Amelia J. McGuinness, Michael Berk, David Castle, Eugene Athan, Christopher Hair, Philip Strandwitz, Amy Loughman, Andrew A. Nierenberg, John F. Cryan, Mohammadreza Mohebbi, Felice N. Jacka

Bibliographic record

VenueResearch Square · 2022
Typepreprint
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGut microbiota and health
Canadian institutionsUniversity of Toronto
FundersSeqirusNational Health and Medical Research CouncilServierState Government of VictoriaMedical Research CouncilAustralian Rotary HealthUniversity of OxfordH. Lundbeck A/SUniversity of CambridgeWellcome Trust
KeywordsProtocol (science)Fecal bacteriotherapyRandomized controlled trialMedicineInternal medicineBiologyAlternative medicineMicrobiologyPathologyAntibiotics

Abstract

fetched live from OpenAlex

Abstract Background Mental disorders, including major depressive disorder (MDD), are a leading cause of non-fatal burden of disease globally. Current conventional treatments for depression have significant limitations, and there have been few new treatments in decades. The microbiota-gut-brain- axis is now recognised as playing a role in mental and brain health, and promising preclinical and clinical data suggest Faecal Microbiota Transplants (FMT) may be efficacious for treating a range of mental illnesses. However, there are no existing published studies in humans evaluating the efficacy of FMT for MDD.Methods and designThis protocol describes an 8-week, triple-blind, 2:1 parallel group, randomised controlled pilot trial (n=15), of enema-delivered FMT treatment (n=10) compared with a placebo enema (n=5) in adults with moderate-to-severe MDD. There will be a further 26-week follow up to monitor longer-term safety. Participants will receive four FMT or placebo enemas over four consecutive days. The primary aims of the study are to evaluate feasibility and safety of FMT as an adjunctive treatment for MDD in adults. Changes in gut microbiota will be assessed as a secondary outcome. Other data will be collected, including changes in depression and anxiety symptoms, and safety parameters.DiscussionModification of the microbiota-gut-brain axis via FMT is a promising potential treatment for MDD, but there are no published rigorous clinical trials evaluating its use. If this study finds that our FMT strategy is safe and feasible, a larger fully powered RCT is planned. Further high-quality research in this field is urgently needed to address unmet need.Trial registration: Australian and New Zealand Clinical Trials Registry: ACTRN12621000932864

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.029
metaresearch head score (Gemma)0.027
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.058
Threshold uncertainty score0.193

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0290.027
Meta-epidemiology (narrow)0.0060.003
Meta-epidemiology (broad)0.0110.005
Bibliometrics0.0020.002
Science and technology studies0.0030.004
Scholarly communication0.0040.004
Open science0.0030.002
Research integrity0.0070.007
Insufficient payload (model declined to judge)0.0580.011

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.073
GPT teacher head0.443
Teacher spread0.370 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueResearch Square→Same topicGut microbiota and health→French-language works237,207→